Comparison

Descarbamoyl Cefuroxime-d3 European Partner

Item no. HY-135372S-100mg
Manufacturer MedChem Express
CASRN 1803241-02-2
Amount 100 mg
Category
Type Chemicals
Specific against other
Citations [1].Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. <br> [2].Vercheval C, et al. Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion. J Chemother. 2018 Oct - Dec;30(6-8):371-374. <br> [3].Takaya T, et al. Studies on beta-lactam antibiotics. III. Synthesis and enzymatic stability of 3-acyloxymethyl-7 beta-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-cephem-4-carboxylic acids. J Antibiot (Tokyo). 1981 Oct;34(10):1300-10.
Smiles O=C(C(N12)=C(CO)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC([2H])([2H])[2H])=O)C1=O)O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
Descarbamoyl Cefuroxime-d3 is the deuterium labeled Descarbamoyl cefuroxime. Descarbamoyl cefuroxime is a degradation product of Cefuroxime. Descarbamoyl cefuroxime is also an intermediate for the synthesis of Cephalosporin antibiotics.
StorageTemperature
Please store the product under the recommended conditions in the Certificate of Analysis.
MolecularWeight
384.38
Research_Area
Infection
Target
Drug Metabolite
Pathway
Metabolic Enzyme/Protease

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: Out of stock
Questions about this Product?
 
Close